Altimmune, Inc.

Historical 13F Holders

Symbol
ALT
CUSIP
02155H200
All holders as of
Q3 2026
Type
Equity
Class
COM NEW
Reported Value, Excluding Options
Total Shares Held, Excluding Options
Total Filers

13D/G Filers

Each filer's latest filing for 02155H200 since 12/18/2024, largest first.

Filer % of Class Filed
Deep Track Capital, LP 13G
10.0% 4/30/2026
Event 4/23/2026
BlackRock, Inc. 13G/A 7.6% 7/16/2025
Event 6/30/2025
Viking Global Investors LP 13G
6.7% 5/1/2026
Event 4/24/2026
RA Capital Management, L.P. 13G
6.5% 5/1/2026
Event 4/24/2026
Under 5%, checked the "5 percent or less" box, or amended by a later filing (5)
TCG Crossover GP II, LLC 13G/A
4.9% 11/16/2026
Event 9/30/2026
State Street Corp 13G 4.3% 11/10/2026
Event 9/30/2026
Ameriprise Financial, Inc. 13G/A
1.9% 5/15/2025
Event 3/31/2025
Tang Capital Management LLC 13G/A
0.3% 5/15/2026
Event 3/31/2026
Vanguard Group Inc 13G/A 0% 3/26/2026
Event 3/13/2026

13F Holders by Quarter

Period Filers Shares, Excl. Options Value, Excl. Options
2026 Q3 194 142 M $407M
2026 Q2 211 150 M $456M
2026 Q1 174 69.4 M $214M
2025 Q4 187 55.1 M $199M
2025 Q3 164 41.5 M $157M
2025 Q2 190 37.6 M $146M
2025 Q1 184 38.2 M $191M
2024 Q4 186 40.5 M $292M
2024 Q3 170 39.5 M $243M
2024 Q2 175 42.4 M $282M
2024 Q1 174 44.5 M $453M
2023 Q4 145 33.5 M $377M
2023 Q3 113 30.3 M $79.1M
2023 Q2 120 35.3 M $125M
2023 Q1 138 43.4 M $205M
2022 Q4 135 46.8 M $1.03B
2022 Q3 128 46.0 M $588M
2022 Q2 115 39.9 M $467M
2022 Q1 105 33.7 M $207M
2021 Q4 104 32.5 M $296M
2021 Q3 121 32.9 M $375M
2021 Q2 112 27.3 M $269M
2021 Q1 98 23.8 M $337M
2020 Q4 90 20.5 M $231M
2020 Q3 76 21.9 M $289M
2020 Q2 63 13.3 M $143M
2020 Q1 33 1.59 M $5.09M
2019 Q4 29 1.30 M $2.44M
2019 Q3 31 1.12 M $2.18M
2019 Q2 22 1.08 M $2.58M
2019 Q1 22 1.12 M $3.24M
2018 Q4 26 808 k $1.66M
2018 Q3 16 194 k $853k
2017 Q3 1 100 $232
2017 Q2 1 100 $320